Own Wesfarmers shares? Here's where the health business is heading

The Wesfarmers share price is down 4% on no official news, but details have emerged about the company's new health division.

| More on:
A smiling woman applies face cream to her cheeks while looking in a mirror.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

sdf

Key points

  • Wesfarmers has created a health division by purchasing Australian Pharmaceutical Industries (API) in March 2022 
  • The managing director of the new health segment plans to leverage API's loyalty program to boost sales 
  • She also wants to build 30 more Clear Skincare clinics 

The Wesfarmers Ltd (ASX: WES) share price is having a terrible day, down 4% in afternoon trading to $43.33.

There's been no market-sensitive news issued by the diversified conglomerate today.

However, according to an article in the Australian Financial Review (AFR), Wesfarmers has been busy with a bunch of changes to the businesses in its new health segment following the purchase of Australian Pharmaceutical Industries (API).

Wesfarmers bought API in a takeover deal finalised in March. The acquisition brought retail chains including Priceline Pharmacy, Pharmacist Advice, and Clear Skincare into the Wesfarmers portfolio.

Best known for owning Bunnings, Kmart, and Officeworks, the purchase represents Wesfarmers' first foray into the healthcare, beauty, and wellness space.

What will API do to the Wesfarmers share price?

Emily Amos is managing director of Wesfarmers' health segment. She was appointed in April shortly after the takeover was concluded.

Amos has done an interview with AFR outlining some of her first priorities.

According to the article, one of them is leveraging API's loyalty program to boost sales. It's the fourth largest of its kind in terms of market penetration in Australia.

Called Sister Club, the loyalty program has 7.5 million members. Amos wants to use it to increase sales, expand product ranges, and improve marketing.

She also wants to expand the network of Clear Skincare clinics, which offers anti-ageing, acne and laser treatments. There are currently 96 clinics across Australia and New Zealand. Amos wants to add 30 more.

Amos told AFR: "It's a good margin business, so it's really about operational execution and discipline."

The former API wholesale drug business recorded $3 billion in sales in fiscal year 2021 but with low margins.

Amos reckons she can improve things by making the distribution centre in Sydney's Marsden Park more efficient. She sees automation as the way to go and expects gains from the second half of this year, according to the article.

Bringing a new business into the fold involves many costs but also many potential rewards.

In Wesfarmers' FY22 full-year results, the health division recorded $1,240 million in revenue. But this trickled down to a $25 million loss in earnings before tax (EBT).

Of course, this is only over the three months that Wesfarmers owned its new health assets.

The picture changes if you take out $36 billion in acquisition-related and one-off expenses. In that scenario, earnings for the three-month period were $11 million.

Over this three-month timeframe, the Wesfarmers share price went down by 15%.

Motley Fool contributor Bronwyn Allen has positions in Wesfarmers Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

A block of cheese with grated cheese on top.
Consumer Staples & Discretionary Shares

Macquarie expects 20% upside for this ASX All Ords consumer staples stock

This week, Macquarie initiated coverage on Bega Cheese with an outperform rating.

Read more »

Man with a hand on his head looks at a red stock market chart showing a falling share price.
Consumer Staples & Discretionary Shares

Why are Cettire shares crashing 27% today?

Things aren't looking good for this online luxury products retailer.

Read more »

Young lady in JB Hi-Fi electronics store checking out laptops for sale
Consumer Staples & Discretionary Shares

Does Macquarie prefer Harvey Norman or JB Hi-Fi shares?

Here’s what this broker has to say about these consumer discretionary companies. 

Read more »

Happy couple doing grocery shopping together.
Consumer Staples & Discretionary Shares

What does Macquarie think Woolworths and Coles shares are worth?

Should investors be interested in supermarket stocks?

Read more »

A man looking at his laptop and thinking.
Broker Notes

Up 17% in 2025, how much more upside does Macquarie tip for Metcash shares?

Following Tuesday’s merger and earnings news, Macquarie changed its rating for Metcash shares.

Read more »

Woman calculating dividends on calculator and working on a laptop.
Consumer Staples & Discretionary Shares

$10,000 invested in these consumer discretionary shares 5 years ago is now worth…

These ASX 200 companies have given investors big returns.

Read more »

Couple looking very happy while shopping at a home improvement store.
Dividend Investing

Focused on pasive income? Check out this defensive ASX 200 dividend stock

A leading expert says this quality ASX 200 dividend stock remains ‘undervalued’.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Consumer Staples & Discretionary Shares

Guess which ASX 200 share is pushing higher on guidance update

This wholesaler is expecting earnings ahead of consensus estimates in FY 2025.

Read more »